为1型糖尿病的新兴成年人制定过渡计划:质量改善倡议
Elizabeth A Minchau1, Billie S Vance2, Emily Barnes3
1Department of Adult Health, School of Nursing, West Virginia University (Dr. Minchau), Morgantown, WV, USA.
Health care transitions
|December 23, 2024
概括
一项针对1型糖尿病 (T1D) 青少年的新过渡计划改善了护理协调. 这种结构化的方法有助于新兴成年人管理T1D,减少并发症并增强自我管理技能.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 医疗保健过渡期 医疗保健过渡期
- 提高质量 提高质量
背景情况:
- 患有1型糖尿病 (T1D) 的新兴成年人在血糖管理方面面临重大挑战,原因是医疗保健过渡不组织.
- 在此期间的护理缺口导致医疗保健利用率低下,糖尿病控制恶化,并发症增加和心理健康问题.
- 正式的过渡计划对于防止护理差距和改善自我管理至关重要.
研究的目的:
- 为患有T1D的青少年在儿科内分泌学诊所开发和实施正式的过渡计划.
- 准备年轻人过渡到成人医疗机构,解决T1D管理的特定需求.
主要方法:
- 利用了医疗改进研究所的改进模型,并获得了过渡的六个核心元素.
- 美国糖尿病协会 (ADA) 针对T1D特异性过渡需求的调整指南.
- 为16-18岁的青少年设计了一个有结构的访问计划,集成到电子健康记录中,并通过焦点小组进行评估.
主要成果:
- 诊所内的过渡活动显著增加.
- 临床合作伙伴的反证实了该计划的可接受性和实用性.
- 该计划的设计得到了重点小组讨论中确定的主题的支持.
结论:
- 整合了Got过渡框架和ADA建议,有效地满足了T1D青少年的需求.
- 将过渡活动纳入电子健康记录可以简化诊所的工作流程.
- 这个倡议为扩大儿科专科护理的过渡计划提供了一个模型.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Emerging Adulthood
39
Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
39
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes: Management and Pharmacotherapy
234
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
234
Diabetes: Symptoms, Diagnosis, and Complications
503
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
503
Insulin: Dosing Regimen and Adverse Effects
142
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
142


